INS and metabolic disease: The evidence suggests that exosomal long non-coding (exo-lncRNAs) are altered in the biofluids (such as blood, vitreous humor, and tears) of patients with metabolic disorders and correlate with key metabolic parameters, including body mass index, inflammation, and insulin sensitivity.